Found 405 clinical trials
-
Phase 2 trial
-
Accepting adults
-
For all genders
-
Currently Recruiting
Schizophrenia Relapse Prevention
This study tests whether the investigational drug prevents patients with schizophrenia from becoming worse. This study looks at how well patients tolerate the investigational drug and how
- 50 views
- 23 Nov, 2020
- 1 location
-
Phase 3 trial
-
Accepting adults
-
For all genders
-
Pediatrics/Neonatology
-
Currently Recruiting
Study Seeking Patients with Schizophrenia
Study Seeking Patients with Schizophrenia
- 0 views
- 07 Nov, 2020
- 6 locations
-
Phase 3 trial
-
Accepting pediatric ages
-
Accepting adults
-
For all genders
-
Currently Recruiting
Treatment of Adolescents With Schizophrenia
This study is being conducted to determine the safety & efficacy of brexpiprazole monotherapy in the treatment of adolescents with schizophrenia.
- 36 views
- 23 Nov, 2020
- 1 location
-
Phase 2 trial
-
Accepting adults
-
For all genders
-
Currently Recruiting
Schizophrenia with Changes in Thinking Skills
Local study doctors are conducting this clinical research study to learn more about an oral investigational drug that is taken with your current schizophrenia medication. They want to evaluate the
- 77 views
- 23 Nov, 2020
- 1 location
-
Phase 2 trial
-
Accepting adults
-
For all genders
-
Currently Recruiting
Add-On Treatment for Schizophrenia Symptom Management
schizophrenia in adults, when added to your current schizophrenia treatment.
- 42 views
- 23 Nov, 2020
- 1 location
-
Phase 2 trial
-
Accepting adults
-
For all genders
-
Currently Recruiting
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia.
schizophrenia on stable antipsychotic treatment.
- 19 views
- 23 Nov, 2020
- 1 location
-
Phase 3 trial
-
Accepting adults
-
For all genders
-
Currently Recruiting
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects with Schizophrenia Treated Prospectively for 6-months with Abilify MyCite®
To compare inpatient psychiatric hospitalization rates (proportion of subjects with ≥ 1 inpatient psychiatric hospitalizations) between the retrospective period (Months 1 to 3) while subjects are on oral standard-of-care antipsychotic treatment and the prospective period (Months 1 to 3) after the subjects switch to Abilify MyCite®.
- 26 views
- 23 Nov, 2020
- 1 location
-
Phase 2 trial
-
Accepting adults
-
For all genders
-
Currently Recruiting
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adult Patients with Schizophrenia and Recent Weight Gain While Taking Antipsychotic Medications
To assess the efficacy of miricorilant compared with placebo in reversing recent antipsychoticinduced weight gain (AIWG)
- 45 views
- 23 Nov, 2020
- 1 location
-
Phase 2 trial
-
Accepting adults
-
For all genders
-
Currently Recruiting
A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily with adjunctive Computerized Cognitive Training over 12 week treatment period in patients with schizophrenia
This study tests whether BI 425809 together with brain training using a computer improves mental functioning in patients with schizophrenia.  
- 51 views
- 23 Nov, 2020
- 1 location